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Abstract
Background: Oncogenetic counselling is seldom followed through, even when individuals are
eligible according to the test criteria. The basic variables which influence the decision to undergo
the genetic counselling process are: risk perception, expected benefit or limitations of genetic
testing, general psychological distress or cancer-specific distress, lack of trust in one's emotional
reactions when faced with negative events, expected level of family support and communications
within the family. The aim of this study was to describe the psychosocial variables of an Italian
sample that forgoes genetic counselling.
Methods: From May 2002 to December 2006 a psychological questionnaire was sent out to one
hundred and six subjects, who freely requested a first genetic informative consultation, and never
asked to have a second visit and the family tree drawn up in order to inquire about their eligibility
for genetic testing. Statistical analysis was performed by Pearson chi-square test, t-test and
Spearman RHO coefficient.
Results: The survey presents a lack of emotional cohesion and structured roles and rules within
the family system and a positive correlation between the number of children, anxiety and risk
perception. The main reasons for giving up on counselling were a sense that testing was a waste of
time and the inability to emotionally handle the negative consequences of the test outcome. The
subjects who maintained that test and an early diagnosis were a "waste of time" experienced more
anxiety.
Conclusion: The study revealed the importance to ac knowledging the whole persona and their
family system as well as provide information highlighting usefulness of early diagnosis.
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Background
The possibility of taking advantage of genetic counselling
for familial/hereditary breast/ovarian cancer enables a
woman, with a family history of cancer, to understand
their risk of developing the disease during their life time
and undertake adequate provision to manage the risk
through a programme of clinical observation or eventual
precautionary surgery. Furthermore, the possibility of
being made aware of one's risk, also enables the counse-
lees to protect their family and in particular their children,
involving them in the process of genetic counselling and
prevention programs.
A number of studies have reported that counselees claim
a great interest in undergoing the genetic test[1-3]; but it
is a fact that, in the same studies the number of subjects
who actually underwent the genetic test, even if they com-
plied with the eligibility criteria, is decidedly low [4]. The
literature concerning the psychological side of onco-
genetic counselling often focuses on the variables which
influence the decision to undergo the test and show some
basic variables such as; estimated cancer risk [2,5],
expected benefit or limitations of genetic testing, [6-8],
general psychological distress or cancer-specific distress
[7,9], lack of trust in one's emotional reactions when
faced with negative events[10], expected level of family
support and communications within the family[11-13].
The present study aims at describing some psychosocial
variables in an Italian group of patients who interrupted
the process of genetic counselling for hereditary/familial
breast/ovarian cancer, following an initial informative
session. Furthermore, it aims at evaluating motivations,
reported by the subjects themselves, which have led to
their decision to discontinue the process of counselling
and probable association between motivation and psy-
chosocial variables.
Methods
From May 2002 to December 2006, 380 subjects
requested a first appointment for genetic counselling at
the Department for Hereditary Tumours of the Breast and/
or Ovaries of "Regina Elena" National Cancer Institute of
Rome. An informative pre-counselling session by the pri-
mary care physician is not envisaged, the subjects freely
telephone the out-patient office to learn one's risk of
developing a breast and/or ovarian tumour. During the
initial informative genetic session the oncologist, sup-
ported by a psychologist, supplies the patient information
concerning BRCA1 and BRCA2 mutation genes which pre-
disposes one to breast/ovarian tumours, concerning the
method of transmission, the possibility of prevention and
treatment of hereditary pathologies.
The physician offers the counselee to initiate the next
appointment in which a family history will be obtained
and eligibility for genetic testing will be determined.
Of these 380 subjects who received the first counselling
informative session, 106 never asked for a second coun-
selling session to have the family tree drawn up in order
to inquire about their eligibility for genetic testing, 28% of
the sample.
These 106 subjects were contacted by telephone by a psy-
chologist, in order to request participation in the study.
Once permission from patients was obtained, some ques-
tionnaires were sent out to be filled in by the counselee
and returned in the enclosed stamped envelope provided.
This was to be done within 20 days following the first con-
tact, failing which, a second telephone call was made,
requesting the return of the questionnaire. The subject
was dropped from the study if their questionnaire was not
received in forty days. All the procedure was discussed and
approved by local Ethic Committee.
Study Population
From December 2006 to March 2007, 106 subjects, 3 men
and 103 women, were contacted. Six subjects refused to
take part in the study, 35 did not return the questionnaire,
and 9 sent them back incomplete. The study was then car-
ried out on a sample of 56 subjects, 2 men and 54 women,
affected by breast and/or ovarian cancer, or healthy but
with a family history of cancer (at least one affected rela-
tive). 53% took part in the study.
Instruments
Form for the socio-demographic and medical characteristics
The test variables were; age, gender, place of birth, civil
status, number of children, education, employment, reli-
gion or whether they are practicing, cancer, number of rel-
atives affected by cancer.
Cancer Risk Perception (CRP)
One item taken from prior research [14,15], was to evalu-
ate the possible risk of the subject developing cancer. "
Mark with a cross on a scale of 0 to 100 what you consider
to be your risk of developing, or re-developing, breast and
ovarian cancer". Reply was given on a Visual analogue
scale of 0 to 100%: 0 representing the lowest risk, 100 the
highest and a blank space "do not know".
Genetic Risk Perception (GRP)
Another item taken from prior research[16], was to evalu-
ate the likelihood to be a carrier of the BRCA1/BRCA2
genetic mutation. " Mark with a cross on a scale of 0 to
100 what you consider to be your risk of being a carrier of
the genetic mutation predisposing one to breast and ovar-
ian cancer". Reply was given on a Visual Analogue ScaleJournal of Experimental & Clinical Cancer Research 2008, 27:75 http://www.jeccr.com/content/27/1/75
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from 0 to 100%; 0 representing the lowest risk, 100 the
highest and a blank space "do not know".
Anxiety and Depression
The Hospital Anxiety and Depression Scale (HADS) [17],
Italian version and mean score [18], is used in literature to
evaluate the psychological distress in a non-psychiatric
setting. It is composed of two scales of 14 items, 7 regard-
ing anxiety and 7 regarding depression. The two scores can
be calculated separately with three cut-offs: normal (0–7),
borderline (8–10) disturbance (above 11). By calculating
the sum of the two scales, it is possible to identify the pres-
ence of disturbance in adaptation(cut-off 13–18), or an
episode of heavy depression (cut-off > 19). No psycholog-
ical distress is evidenced if the sum of the two scores totals
< 13.
Family structure and functioning
Family Adaptability and Cohesion Evaluation Scale
(FACES III) of D.H. Olson [19], Italian version by Galim-
berti C. and Farina M. [20], reliability within this sample
α = 0,847, evaluates the perception of family functioning
on the basis of adaptability and cohesion according to a
Circumplex model developed by David Olson et.al. There
are four levels of family cohesion (disengaged, separated,
connected and enmeshed), and four levels of adaptability
(rigid, structured, flexible and chaotic).
This Circumplex model classifies the family into 16 spe-
cific types, or more generally, according to a three-way
division defined as " balanced", "mid-range" and
"extreme". Moreover, this measure is used to obtain infor-
mation about the true or ideal functioning of families The
discrepancy between the true and ideal family indicates
the measure of family dissatisfaction The test is made up
of 40 multiple-choice items (20 for the actual family, 20
for the ideal).
Motivation
A questionnaire was composed of 22 true/false items to
indicate the reasons behind the decision to choose not to
pursue genetic counselling. The questionnaire was
adapted from prior research to indicate limitations and
benefits derived from the test [3] as well as to ascertain
possible barriers to undergoing screening, as perceived by
women [21].
Statistics
Descriptive statistics were used to summarize the perti-
nent information. Association between dichotomous or
categorical variables was tested by the Pearson Chi-Square
test (for the trend when necessary). Rank-order correla-
tion was measured by the Spearman RHO coefficient. The
SPSS (11.0) statistical program was used for analysis.
Results
Sample description
The description of the sample is reported in table 1 (socio-
demographic and medical characteristics) and in table 2
(psychological characteristics; *14 subjects do not know
how to express their risk of breast and/or ovarian cancer
and **15 subjects do not know how to express their risk
of being carriers of the genetic BRCA1 e BRCA2 mutation
genes).
Socio-demographic and medical characteristics
The sample was made up of 56 subjects, 2 men and 54
women. Eighteen were affected by breast or ovarian can-
cer (1 male breast tumour). Thirty-eight were healthy but
with a family history of cancer. The average age was 48.6
years and the average number of family members affected
by cancer was 3.9.
Most of the sample were Roman Catholic (92%), but only
50% claimed to be practicing, 46% had finished high
school, 19% had a university degree and more than a third
of the sample had a middle or elementary school level.
Seventy percent were married and 73% had at least one
child. An equal number of subjects were either unem-
ployed or employed (52%v 48%). There are no significant
differences between cancer affected women and healthy
women regarding socio-demographic characteristics, risk
perception and anxiety levels.
Table 1: Socio-demographic and medical characteristics
N = 56 subjects Mean Range
Age 48,6 27–70
Number of relatives affected by cancer 3,9 0–13
Frequency %
Status
Single 17 30,4
Married 39 69,6
Number of children
No children 15 26,8
Up to two children 29 51,8
More than two children 12 21,4
Education
Elementary and middle 19 33,9
Higher 26 46,4
Degree 11 19,6
Work
Workers 27 48,2
Non workers 29 51,8
Religion
Roman Catholic 52 92,9
Other 4 7,1
Practicing
Practicing 28 50
Non practicing 28 50
Disease
Affected 18 32,1
Not affected 38 67,9Journal of Experimental & Clinical Cancer Research 2008, 27:75 http://www.jeccr.com/content/27/1/75
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Risk Perception of developing breast and ovarian cancer
The mean percentage of risk perception of developing
cancer is 49.8%. The score was correlated positively with
the number of children (p = 0.01 r = 0.371) and with the
level of anxiety (p = 0.07 r = 0.274). 25% of the subjects
could give no indication of their risk perception of devel-
oping breast/ovarian cancer.
Risk perception of being a carrier of the genetic mutation
The mean percentage of risk perception of being a carrier
of BRCA1 and BRCA2 mutation shown is 46.7%. this
score was positively correlated with the number of chil-
dren (p > 0.04 r = 0.338) and level of anxiety (p = 0.04 r =
0.332), and 26,7% of subjects could give no indication of
their perception of risk of being a carrier of genetic muta-
tion predisposing one to breast/ovarian cancer.
Anxiety and Depression
The mean total score obtained from the HAD scale is
within the cut off for adaptation disorders (13.9). In
46.4% of subjects there were no signs of anxiety or depres-
sion, the rest of the sample showed an equal distribution
between a major depressive episode (26.8%) and adapta-
tion disorders (26.8%). In each scale there was an average
score of 8.3 (borderline anxiety) and 5.6 (normal depres-
sion).
The borderline anxiety level was 30.4%, anxiety disorders
25%, depressive disorders 12.5% and the same percentage
of subjects had a borderline level of depression. The score
for the single scale of anxiety correlated with the number
of children (p = 0.001 r = 0.421).
Family Adaptability and Cohesion Evaluation Scale (FACES III)
The average score of true and ideal cohesion were 39.7
(separated families) and 42.1 (connected families),
respectively. The mean index of family dissatisfaction for
cohesion was -2.35 (negative sign indicates a general ten-
dency for family members to want closer emotional ties).
The average of true and ideal adaptability was 30.1 and
34.5 (range of chaotic families for both values) The aver-
age index of family dissatisfaction with adaptability was -
4.50 (negative score indicates the desire for change
towards greater structuring of rules/roles between family
members). A third of the families were considered to be
extreme 30%, mid-range 59%, and balanced only 11%.
Reasons for discontinuing genetic counselling, and associations 
between socio-demographic, medical and psychological variables. 
(Table 3)
One of the reasons given for discontinuing counselling as
reported by 48% of the subjects is the fear of the conse-
quences for their family brought about by the results of
the genetic test. In particular, 32% believed it was not
right to involve their family. The same percentage of sub-
jects, did not feel they could pass on negative information
to their family, and 9% of subjects felt guilty towards their
family members. Amongst the counselees who claimed
their partner to be against genetic testing, 5.4% harboured
a level of genetic risk perception, significantly lower (p =
0.002) compared to the rest of the sample. Forty-three
percent of counselees showed fear arising from the stress
of hospital visits as their reason for discontinuing the
counselling, a further 43% the fear of knowing that they
had a high risk of developing cancer and 18% felt they
would not be able to confront the idea of frequent pre-
ventative clinical surveillance if they were found to be
mutation carriers. This latter data was reported principally
by subjects affected by cancer and answered 'true' to this
item, significantly more than healthy subjects(p = 0.047).
Thirty four percent of subjects stated that they did not
have the time to attend the visits required for counselling,
this reason was given by significantly more single,
divorced or widowed women compared to married
women (p = 0.048). Thirty seven percent claimed that the
distance between the hospital and their home was the rea-
Table 2: Psychological characteristics
Mean Median St Deviation Range
Anxiety 7,9 7,0 3,7 0–16
Depression 5,1 4,0 3,5 0–15
Real cohesion 39,7 40,0 7,4 11–53
Real adaptability 30,0 30,0 7,1 15–50
Ideal cohesion 42,1 42,0 6,0 22–50
Ideal adaptability 34,5 35,0 5,7 17–46
Real dissatisfaction -2.3 -2.0 8,1 (-25)–(+24)
Ideal dissatisfaction -4.5 -5,0 7,8 (-22)–(+18)
Number of relatives affected by cancer 3,9 3,0 3,2 0–13
Cancer Risk Perception 38,9 46,0 23,8 0–100*
Genetic Risk Perception 39,9 50,0 23,1 0–86.8**Journal of Experimental & Clinical Cancer Research 2008, 27:75 http://www.jeccr.com/content/27/1/75
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son for discontinuing counselling, and 39% held that it
was impossible to obtain an appointment for the visits
because the phone lines were always busy.
Twelve percent maintained they did not have a good
reception from the medical staff, 27% of the subjects had
no desire to know whether or not they were predisposed
to genetic mutation for breast or ovarian cancer. Amongst
these individuals there was an average number of family
members affected by cancer, significantly less than those
who have a desire to know their likelihood of genetic risk
(p = 0.004). Believing the test was a waste of time because
it would not halt the disease, was given as the excuse for
discontinuing counselling by 41%. This group encoun-
tered significantly higher levels of anxiety and depression
(p = 0.03; p = 0.02) than the subjects who felt that genetic
testing was useful. Among the subjects whose motivation
for discontinuing counselling was the idea that genetic
Table 3: Motivation for patient to choose not to pursue genetic counselling
Reasons for discontinuing genetic counselling Frequency Percentage
1) The aim of the genetic testing is not clear 10 17,9
2) I do not feel able to face the stress of hospital visits 24 42,9
3) I am afraid of the consequences of any negative information, for me or my family 27 48,2
4) I do not feel it is fair to involve my family 18 32,1
5) I feel guilty towards my family 58 , 9
6) My family is against genetic testing 47 , 1
7) My partner is against genetic testing 35 , 4
8) I do not want to know if I have a genetic mutation which predisposes me to cancer 15 26,8
9) The test is a waste of time as it will not improve the quality of my life 14 25,0
10) The test is a waste of time as I already have cancer 6 10,7
11) The hospital is too far away 21 37,5
12) I do not have time to do all the visits needed for the genetic testing program 19 33,9
13) Having the test will not prevent me from getting cancer 23 41,1
14) I was not able to get an appointment with the doctor because the administration was unavailable 9 16,1
15) I was not able to get an appointment with the doctor because the phone-line was always engaged 13 23,2
16) The doctor was unavailable 23 , 6
17) I did not feel the medical staff was sufficently welcoming 7 12,5
18) I do not feel I can face the stress of having blood tests 2 3,6
19) I would not be able to tell my family any bad news 18 32,1
20) It would be to hard to know that I would probabely develop cancer 24 42,9
21) If I were to be a carrier of a mutation I could not stand the idea of undergoing frequent check-ups 10 17,9
22) I think early diagnosis is a waste of time 4 7,1Journal of Experimental & Clinical Cancer Research 2008, 27:75 http://www.jeccr.com/content/27/1/75
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investigation does not improve ones quality of life (25%),
higher levels of depression were seen compared to the
subjects who, on the contrary, believed genetic analysis
could improve the quality of life (p = 0.06). Eighteen per-
cent were not sure of the aim of the genetic test, 7% felt
that early diagnosis was a "waste of time" and moreover,
this group had significantly higher levels of anxiety and
depression compared to those who believed early diagno-
sis to be useful(p = 0.02; p = 0.01). Ten percent of the sub-
jects, felt that genetic testing was of no value as they were
already symptomatic.
Discussion
According to available literature, certain similarities and
even novelties in the psychosocial variables emerged in
this Italian sample compared to subjects in other coun-
tries who take advantage of oncological-genetic counsel-
ling. For the risk perception variable, in agreement with
previous works, [4,16,22,23], we found a high risk percep-
tion of developing a tumour of the breast and/or ovaries
and a high risk perception of being carrier of the genetic
mutation BRCA1/BRCA2. Our sample showed a similar
correlation between anxiety and risk perception found in
literature. Literature reports [23,25,26] that a high level of
psychological distress combined with high risk perception
were both found to be predictors of the decision to
undergo the genetic test. Whereas, in our study, the sub-
jects discontinued genetic counselling despite the high
level and combination of psychological distress and risk
perception. One possible explanation of this discrepancy
could be found in the retrospective design of the study.
The sometime late request of informations about the dis-
continuation and assessment of psychological distress
could neither represent a punctual picture of the accuracy
of the counsellor intervention, nor correlate emotional
perturbations at the first step of genetic counselling. How-
ever, the discontinuation from genetic counselling in spite
of a high risk perception could be also explained by taking
into account the difference between general distress and
specific cancer distress. In fact, the latter unease about the
onset of a tumour would seem to be useful in activating
health orientated behaviour [23,26], in particular when
associated with a high risk perception. [23,27]. On the
contrary, high general distress (measured in this study
with HADs) indicated refusal to undergo genetic testing,
thereby reflecting and generating fatalism [28] about the
future. The possibility that the high level of general dis-
tress found in these subjects (disorders of adjustment and
borderline anxiety) was one of the obstacles in the deci-
sion to continue counselling is corroborated also by the
high percentage of the same individuals who felt that
genetic testing was "a waste of time" because it would not
prevent the onset of the disease or improve the quality of
their lives. Of interest, the subjects who have higher levels
of anxiety and depression perceived that the testing and
early diagnosis is of no use. This was in agreement with
the hypothesis in literature that the perceived lack of con-
trol over ones health combined with a high level of gen-
eral distress seems to lead to avoidance or a sense of
fatalism towards prevention [4]. As is true for oncological
genetic testing, so it is for Huntington's syndrome [29,30],
where the awareness of having a mutation is of no help in
changing the course of the disease. In the latter case a
refusal to undergo genetic testing is often found when the
subjects have a high level of general distress caused by
anxiety and depression [31]. Often, the possibility of pro-
tecting one's children through awareness of their risk and
prevention, is a major factor in the decision to undergo
genetic testing [2,4,8,10]. Given this, the lack of motiva-
tion to undergo genetic testing in this sample may be
explained by the perception of not being able to protect
their children, as they see it to be useless for cancer pre-
vention. Therefore, it can be hypothesised that a positive
correlation between the level of anxiety and number of
children may depend on the perception of not being able
to protect them. Furthermore, for the subjects who found
genetic testing to be of no avail because they were already
symptomatic, a lack of knowledge regarding preventive
measures for themselves or their family can also be
hypothesised. This data would seem to give further sup-
port to the continuing attention paid in literature to the
necessity of educational sessions of genetic counselling,
which highlight the importance of diagnosis and the pos-
sibly of adhering to check-up-surveillance programs. A
high percentage of subjects feel incapable of handling
their emotions regarding any eventual negative informa-
tion about themselves or their family, the necessity to
undergo frequent screening and the knowledge of being at
a higher risk of developing breast or ovarian cancer.
The latter data, frequently reported in literature, would
confirm that the "anticipated emotional response" seen as
unmanageable and insupportable, is one of the most fre-
quent variables hindering the decision to undergo genetic
testing. [5,32]. A large percentage of subjects claim they do
not have the time to undergo testing, and it is interesting
to note that they are mainly women who have reported
the loss or absence of a partner (divorced, separate, wid-
ows and single). Furthermore, even certain émpasse of an
organisational form, such as the distance from the hospi-
tal to the home, or busy phone lines seem to have an
influence in the discontinuation of counselling, In agree-
ment with literature, the number of family members
affected by cancer is of great relevance regarding onco-
genetic testing, in fact, the subjects with the least number
of affected relatives say they do not wish to know whether
or not they have a genetic mutation. Another very relevant
variable which has a positive influence over the decision
to undergo testing, is being able to count on the support
of, and good communication within the family [4,11,24].Journal of Experimental & Clinical Cancer Research 2008, 27:75 http://www.jeccr.com/content/27/1/75
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It can be hypothesised that the lack of emotional cohesion
or structured roles and rules within the family system,
seen in this sample, could have a negative influence on
the decision to continue with genetic counselling.
Conclusion
This study showed the importance to take into considera-
tion, during the process of genetic counselling, not only
the single variables but also the whole picture gathered
from the cognitive and emotional aspects from both the
individual and family spheres, in order to assure adequate
care of the patient. Moreover, given the evidence in this
sample of a lack of knowledge regarding preventive meas-
ures for consultants or their family, it appears necessary to
provide information highlighting usefulness of early diag-
nosis, and information regarding how the process of
genetic counselling can be helpful for this purpose.
With the aim of verifying the effective importance of each
variable in the decision to discontinue genetic counsel-
ling, a comparison between subjects who decline or those
who wish to continue genetic counselling will be carried
out in a further study.
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